Found: 25
Select item for more details and to access through your institution.
Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with KRAS p.G13D Mutation.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6037, doi. 10.3390/ijms21176037
- By:
- Publication type:
- Article
Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4934, doi. 10.3390/ijms21144934
- By:
- Publication type:
- Article
Stromal Cells Positively and Negatively Modulate the Growth of Cancer Cells: Stimulation via the PGE2-TNFα-IL-6 Pathway and Inhibition via Secreted GAPDH-E-Cadherin Interaction.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119415
- By:
- Publication type:
- Article
New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Author Correction: Androprostamine A: a unique antiprostate cancer agent.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Androprostamine A: a unique antiprostate cancer agent.
- Published in:
- Journal of Antibiotics, 2021, v. 74, n. 10, p. 717, doi. 10.1038/s41429-021-00449-8
- By:
- Publication type:
- Article
In vivo efficacy of β-lactam/tripropeptin C in a mouse septicemia model and the mechanism of reverse β-lactam resistance in methicillin-resistant Staphylococcus aureus mediated by tripropeptin C.
- Published in:
- Journal of Antibiotics, 2018, v. 71, n. 1, p. 79, doi. 10.1038/ja.2017.88
- By:
- Publication type:
- Article
Biological activity of intervenolin analogs with a phenyl substituent.
- Published in:
- Journal of Antibiotics, 2018, v. 71, n. 1, p. 86, doi. 10.1038/ja.2017.123
- By:
- Publication type:
- Article
Novel autophagy inducers lentztrehaloses A, B and C.
- Published in:
- Journal of Antibiotics, 2015, v. 68, n. 8, p. 521, doi. 10.1038/ja.2015.23
- By:
- Publication type:
- Article
Structure and biological properties of lentztrehalose: a novel trehalose analog.
- Published in:
- Journal of Antibiotics, 2014, v. 67, n. 4, p. 319, doi. 10.1038/ja.2013.143
- By:
- Publication type:
- Article
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.
- Published in:
- Journal of Antibiotics, 2013, v. 66, n. 9, p. 543, doi. 10.1038/ja.2013.42
- By:
- Publication type:
- Article
Suppression of type II collagen-induced arthritis by ICM0301B, a new angiogenesis inhibitor.
- Published in:
- Journal of Antibiotics, 2013, v. 66, n. 4, p. 243, doi. 10.1038/ja.2012.114
- By:
- Publication type:
- Article
NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716.
- Published in:
- Journal of Antibiotics, 2010, v. 63, n. 6, p. 319, doi. 10.1038/ja.2010.42
- By:
- Publication type:
- Article
NBRI17671, a new antitumor compound, produced by Acremonium sp. CR17671.
- Published in:
- Journal of Antibiotics, 2010, v. 63, n. 5, p. 237, doi. 10.1038/ja.2010.28
- By:
- Publication type:
- Article
Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin‐like growth factor‐1 secretion by prostate stromal cells.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 12, p. 3474, doi. 10.1002/ijc.32959
- By:
- Publication type:
- Article
Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 4, p. 810, doi. 10.1002/ijc.24915
- By:
- Publication type:
- Article
Monotherapy with a novel intervenolin derivative, AS‐1934, is an effective treatment for <italic>Helicobacter pylori</italic> infection.
- Published in:
- Helicobacter, 2018, v. 23, n. 2, p. 1, doi. 10.1111/hel.12470
- By:
- Publication type:
- Article
Rediscovery of 4‐Trehalosamine as a Biologically Stable, Mass‐Producible, and Chemically Modifiable Trehalose Analog.
- Published in:
- Advanced Biology, 2022, v. 6, n. 6, p. 1, doi. 10.1002/adbi.202101309
- By:
- Publication type:
- Article
Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
- Published in:
- Journal of Infectious Diseases, 2020, v. 221, n. 5, p. 766, doi. 10.1093/infdis/jiz501
- By:
- Publication type:
- Article
Metacytofilin Is a Potent Therapeutic Drug Candidate for Toxoplasmosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3595, doi. 10.1111/cas.14196
- By:
- Publication type:
- Article
Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.
- Published in:
- Cancer Science, 2014, v. 105, n. 12, p. 1609, doi. 10.1111/cas.12542
- By:
- Publication type:
- Article
Antitumor effects of tyropeptin-boronic acid derivatives. Gene expression analyses of RPMI8226 cells treated with tyropeptin-boronic acid derivatives using Agilent human whole genome microarray.
- Published in:
- 2014
- By:
- Publication type:
- Other
In vivo imaging of proteasome inhibition using a proteasome-sensitive fluorescent reporter.
- Published in:
- Cancer Science, 2012, v. 103, n. 9, p. 1730, doi. 10.1111/j.1349-7006.2012.02352.x
- By:
- Publication type:
- Article
Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis.
- Published in:
- Cancer Science, 2010, v. 101, n. 3, p. 743, doi. 10.1111/j.1349-7006.2009.01438.x
- By:
- Publication type:
- Article